GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kilitch Drugs (India) Ltd (NSE:KILITCH) » Definitions » Accounts Payable & Accrued Expense

Kilitch Drugs (India) (NSE:KILITCH) Accounts Payable & Accrued Expense : ₹365 Mil (As of Sep. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Kilitch Drugs (India) Accounts Payable & Accrued Expense?

Kilitch Drugs (India)'s quarterly accounts payable & accrued expense declined from Mar. 2024 (₹259 Mil) to Jun. 2024 (₹0 Mil) but then increased from Jun. 2024 (₹0 Mil) to Sep. 2024 (₹365 Mil).

Kilitch Drugs (India)'s annual accounts payable & accrued expense declined from Mar. 2022 (₹433 Mil) to Mar. 2023 (₹410 Mil) and declined from Mar. 2023 (₹410 Mil) to Mar. 2024 (₹259 Mil).

Kilitch Drugs (India) Accounts Payable & Accrued Expense Historical Data

The historical data trend for Kilitch Drugs (India)'s Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kilitch Drugs (India) Accounts Payable & Accrued Expense Chart

Kilitch Drugs (India) Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Accounts Payable & Accrued Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 76.08 538.08 433.47 410.41 258.73

Kilitch Drugs (India) Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Accounts Payable & Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 397.51 - 258.73 - 365.11

Kilitch Drugs (India) Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Kilitch Drugs (India) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kilitch Drugs (India) Ltd (NSE:KILITCH) » Definitions » Accounts Payable & Accrued Expense
Comparable Companies
BOM:524731 BOM:541400 BOM:530163 BOM:530477 BOM:524632 BOM:543998 BOM:540937 BOM:533543 NSE:ACCENTMIC BOM:500009 ZTS XTER:MRK NSE:SUNPHARMA LSE:HLN TSE:4502 XSWX:GALD XTAE:TEVA NSE:DIVISLAB XSWX:SDZ VTRS
Traded in Other Exchanges
524500:India
Address
Waman Tukaram Patil Marg, 37/39, Ujagar Industrial Estate, Deonar, Mumbai, MH, IND, 400 088
Website
https://www.kilitch.com
Kilitch Drugs (India) Ltd is an India-based pharmaceutical company. It is engaged in the manufacture and sales of pharmaceutical products. The company offers parenteral and nasal products, oral formulations, effervescent tablets, nutritional products, medical devices, and cosmetic and health products. Some of the products offered by the company are Roipar, Roivit, PH-7, C-Seal, SRO kit, 9-VIT, HPURE, and others. The company has one reportable segment, which is the development and operations of the Pharmaceutical business.

Kilitch Drugs (India) Headlines

No Headlines